← Eichor
Study identifier: NCT06619769 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

eSense-Cancer: Adapting an Online Intervention for Sexual Health Concerns to Gynecologic Cancer

Condition: Gynecologic Cancers  ·  Sponsor: University of British Columbia

PhaseNA
Planned participants60
Who can joinFemale, 19 Years to no upper limit
Healthy volunteersNo

About this study

Sexual health is a vital component of gynecologic cancer treatment and survivorship. Unfortunately, most gynecologic cancer survivors lack sufficient information about the impact of cancer on sexual health and treatment opportunities. This research aims to assess how well an adapted online health intervention meets the sexual health needs of gynecologic cancer survivors and to test the efficacy of the new platform. If successful, eSense-Cancer may increase access to treatment for gynecologic cancer survivors, including those living in remote areas or facing other accessibility barriers. It may also fill healthcare gaps for survivors of varying ethnicity, sexual orientation, socioeconomic status, and gender.

This description comes directly from the study's public registry record.

Talk to the study team

Nisha Marshall, MSc  ·  6048754111  ·  nisha.marshall@cw.bc.ca

Kira McNamee  ·  6048754111  ·  kira.mcnamee@vch.ca

Always discuss trial participation with your own doctor first.

Locations (1)

University of British ColumbiaVancouver, British Columbia, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06619769